Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Sales

Burning Rock Biotech (BNR) Return on Sales: 2020-2024

Historic Return on Sales for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to 0.65%.

  • Burning Rock Biotech's Return on Sales rose 19.00% to 0.12% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.19%, marking a year-over-year increase of 65.00%. This contributed to the annual value of 0.65% for FY2024, which is 56.00% up from last year.
  • As of FY2024, Burning Rock Biotech's Return on Sales stood at 0.65%, which was up 46.23% from 1.21% recorded in FY2023.
  • Burning Rock Biotech's 5-year Return on Sales high stood at 0.65% for FY2024, and its period low was 1.72% during FY2022.
  • Over the past 3 years, Burning Rock Biotech's median Return on Sales value was 1.21% (recorded in 2023), while the average stood at 1.19%.
  • Per our database at Business Quant, Burning Rock Biotech's Return on Sales crashed by 62bps in 2021 and then skyrocketed by 56bps in 2024.
  • Burning Rock Biotech's Return on Sales (MRY) stood at 0.95% in 2020, then plummeted by 65bps to 1.57% in 2021, then fell by 10bps to 1.72% in 2022, then grew by 30bps to 1.21% in 2023, then soared by 46bps to 0.65% in 2024.
  • Its Return on Sales was 0.65% in FY2024, compared to 1.21% in FY2023 and 1.72% in FY2022.